Skip to content
ViraxImmune™
Products
All
ELISpot Kits
ImmuneSelect Peptide Pools
Recombinant Antibodies
Services
Media
Leadership
Contact Us
Investor Relations
Menu
ViraxImmune™
Products
All
ELISpot Kits
ImmuneSelect Peptide Pools
Recombinant Antibodies
Services
Media
Leadership
Contact Us
Investor Relations
£
0.00
0
Cart
Media
Keep up to date with all the latest news and updates from Virax Biolabs.
Blog
Media
Uncategorized
All
June 13, 2024
EVALUATING T CELL DRIVEN IMMUNITY IN POST-VIRAL SYNDROMES
Read more
May 14, 2024
From Rugby Fields to Research Labs with Nigel McCracken (Spotify)
Read more
April 30, 2024
Nigel McCracken & Sean Knight – Research into T-Cell Exhaustion (with Jackie Baxter)
Read more
April 25, 2024
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
Read more
April 16, 2024
Virax Biolabs to Participate at ESCMID Global 2024
Read more
April 10, 2024
Post-Viral Syndromes and the Utility of T cell Diagnostics
Read more
January 8, 2024
James Foster CEO & Nigel McCracken COO – Virax Biolabs (with Don Davis PhD)
Read more
January 4, 2024
Virax Biolabs Partners With University of Manchester, Northern Care Alliance on Long COVID Study
Read more
December 27, 2023
Identifying Post-Viral Syndromes Such as Long COVID
by John Parkinson
Read more
December 21, 2023
Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients
Read more
December 18, 2023
Virax Biolabs’ CEO James Foster Issues Letter to Shareholders
Read more
November 22, 2023
Dr. Nigel McCracken, Ph.D. – Chief Operating Officer, Virax Biolabs
Read more
Page
1
Page
2
Page
3
Page
4
Page
5